What physicians do in case of a failure of the pace-sense part of a defibrillation lead Survey in Germany, Austria and Switzerland

被引:0
|
作者
Lacour, P. [1 ]
Parwani, A. [1 ]
Huemer, M. [1 ]
Attanasio, P. [1 ]
Dang, P. L. [1 ]
Luebcke, J. [1 ]
Schleussner, L. [1 ]
Blaschke, D. [1 ]
Boldt, L-H [1 ]
Pieske, B. [1 ]
Haverkamp, W. [1 ]
Blaschke, F. [1 ]
机构
[1] Charite Univ Med Berlin, Dept Cardiol, Campus Virchow Klinikum, Augustenburger Pl 1, D-13353 Berlin, Germany
关键词
Cardiac implantable electronic device; High-voltage lead; Implantable cardioverter-defibrillator; Medical device failure; Cardiac resynchronization therapy; RIATA LEAD; SAFETY; COMPLICATIONS; DYSFUNCTION; MANAGEMENT; MECHANISM; PACEMAKER; OUTCOMES;
D O I
10.1007/s00059-018-4736-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The possible treatment strategies for defects of the pace-sense (P/S) part of a defibrillation lead are either implantation of a new high-voltage (HV)-P/S lead, with or without extraction of the malfunctioning lead, or implantation of a P/S lead. Methods We conducted a Web-based survey across cardiac implantable electronic device (CIED) centers to investigate their procedural practice and decision-making process in cases of failure of the P/S portion of defibrillation leads. In particular, we focused on the question of whether the integrity of the HV circuit is confirmed by a test shock before decision-making. The questionnaire included 14 questions and was sent to 951 German, 341 Austrian, and 120 Swiss centers. Results The survey was completed by 183 of the 1412 centers surveyed (12.7% response rate). Most centers (90.2%) do not conduct a test shock to confirm the integrity of the HV circuit before decision-making. Procedural practice in lead management varies depending on the presentation of lead failure and whether the center applies a test shock. In centers that do not conduct a test shock, the majority (69.9%) implant a new HV-P/S lead. Most centers (61.7%) that test the integrity of the HV system implant a P/S lead. The majority of centers favor DF-4 connectors (74.1%) over DF-1 connectors (25.9%) at first CIED implantation. Conclusion Either implanting a new HV-P/S lead or placing an additional P/S lead are selected strategies if the implantable cardioverter-defibrillator lead failure is localized to the P/S portion. However, conducting a test shock to confirm the integrity of the HV component is rarely performed.
引用
下载
收藏
页码:362 / 368
页数:7
相关论文
共 3 条
  • [1] What physicians do in case of a failure of the pace-sense part of a defibrillation lead: Survey in Germany, Austria and Switzerland; [Was Ärzte bei Versagen des Pace-Sense Anteils von Defibrillationselektroden tun: Eine Umfrage in Deutschland, Österreich und der Schweiz]
    Lacour P.
    Parwani A.
    Huemer M.
    Attanasio P.
    Dang P.L.
    Luebcke J.
    Schleussner L.
    Blaschke D.
    Boldt L.-H.
    Pieske B.
    Haverkamp W.
    Blaschke F.
    Herz, 2020, 45 (4) : 362 - 368
  • [2] What do hematologists and oncologists consider necessary for their career? Results of an online survey in Germany, Austria and Switzerland
    Marianne Giesler
    Maike Busson-Spielberger
    Bärbel Miemietz
    Maike de Wit
    Katja Weisel
    Diana Lüftner
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5331 - 5344
  • [3] What do hematologists and oncologists consider necessary for their career? Results of an online survey in Germany, Austria and Switzerland
    Giesler, Marianne
    Busson-Spielberger, Maike
    Miemietz, Barbel
    de Wit, Maike
    Weisel, Katja
    Lueftner, Diana
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (08) : 5331 - 5344